Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Jun 15, 2019; 11(6): 489-498
Published online Jun 15, 2019. doi: 10.4251/wjgo.v11.i6.489
Published online Jun 15, 2019. doi: 10.4251/wjgo.v11.i6.489
Table 1 Basic information of stent implantation group and combined treatment group
Group | n | Age (yr) | Sex | Bismuth classification (cases) | Implantation method | ||||
M | F | II | III | IV | Unilateral | Bilateral | |||
Control (35 cases) | 61.6 ± 7.1 | 15 | 20 | 2 | 18 | 15 | 4 | 31 | |
Stent | 13 | 5 | 8 | 2 | 7 | 4 | 4 | 9 | |
Drainage tube | 22 | 10 | 12 | 0 | 11 | 11 | 0 | 22 | |
Combined (37 cases) | 58.2 ± 7.7 | 19 | 18 | 4 | 18 | 15 | 7 | 30 | |
Stent | 21 | 14 | 7 | 4 | 12 | 5 | 7 | 14 | |
Drainage tube | 16 | 5 | 11 | 0 | 6 | 10 | 0 | 16 | |
P-value | 0.91 | 0.49 | 0.74 | 0.88 |
- Citation: Zheng WH, Yu T, Luo YH, Wang Y, Liu YF, Hua XD, Lin J, Ma ZH, Ai FL, Wang TL. Clinical efficacy of gemcitabine and cisplatin-based transcatheter arterial chemoembolization combined with radiotherapy in hilar cholangiocarcinoma. World J Gastrointest Oncol 2019; 11(6): 489-498
- URL: https://www.wjgnet.com/1948-5204/full/v11/i6/489.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i6.489